Javascript must be enabled to continue!
Eli’s Impact: A Case Study
View through CrossRef
This chapter illustrates the continuing powerful influence of Eli Stein's ideas. It starts by recalling his ideas on Littlewood–Paley theory, as well as several major developments in pure and applied mathematics, to which those ideas gave rise. Before Eli, Littlewood–Paley theory was one of the deepest parts of the classical study of Fourier series in one variable. Stein, however, found the right viewpoint to develop Littlewood–Paley theory and went on to develop Littlewood–Paley theory on any compact Lie group, and then in any setting in which there is a reasonable heat kernel. Afterward, the chapter discusses the remarkable recent work of Gressman and Strain on the Boltzmann equation, and explains in particular its connection to Stein's work.
Title: Eli’s Impact: A Case Study
Description:
This chapter illustrates the continuing powerful influence of Eli Stein's ideas.
It starts by recalling his ideas on Littlewood–Paley theory, as well as several major developments in pure and applied mathematics, to which those ideas gave rise.
Before Eli, Littlewood–Paley theory was one of the deepest parts of the classical study of Fourier series in one variable.
Stein, however, found the right viewpoint to develop Littlewood–Paley theory and went on to develop Littlewood–Paley theory on any compact Lie group, and then in any setting in which there is a reasonable heat kernel.
Afterward, the chapter discusses the remarkable recent work of Gressman and Strain on the Boltzmann equation, and explains in particular its connection to Stein's work.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
333-OR: Oxyntomodulin Analog LY3305677 (LY) Improves Glycemic Control and Weight Loss in Healthy Volunteers and Subjects with Type 2 Diabetes (T2D)
333-OR: Oxyntomodulin Analog LY3305677 (LY) Improves Glycemic Control and Weight Loss in Healthy Volunteers and Subjects with Type 2 Diabetes (T2D)
LY is an acylated peptide analog of oxyntomodulin, a dual glucagon and GLP-1 receptor agonist. We conducted 2 randomized, double-blind, phase 1 multiple ascending subcutaneous dosi...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct
Introduction
Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
Fibroblast growth factor 21 (FGF21) is a liver-secreted peptide hormone reportedly improving metabolic homeostasis, partly via reduced hunger for sugar, fat, protein and alcohol. E...
Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D)
Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D)
Vulnerability to hypoglycemia increases with age. To further assess the safety of insulin in older patients, the risk of hypoglycemia was investigated post-hoc in the SWITCH 2 trea...
30-OR: Empagliflozin Delays Need for Insulin Initiation in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from EMPA-REG OUTCOME
30-OR: Empagliflozin Delays Need for Insulin Initiation in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from EMPA-REG OUTCOME
Insulin in T2D is associated with hypoglycemia and weight gain, requires training, can be expensive, and is generally not preferred by patients. Reducing insulin needs is attractiv...

